Alembic Pharma gets final US nod for generic Mesalamine capsules

The approval granted by the US Food Drug Administration (USFDA) for the abbreviated new drug application (ANDA) for Mesalamine Extended-Release Capsules of strength 0.375 g, the company said in a statement.

from Moneycontrol Business News https://ift.tt/ijZXKvG